(R) -1-Boc-3-Aminopiperidine CAS 188111-79-7 Puritas >99.5% (GC) ee >99.5%

Description:

Nomen chemicum: (R)-1-Boc-3-Aminopiperidine

Synonyma: (R)-(-)-3-Amino-1-Boc-Piperidine

CAS: 188111-79-7

Puritas: >99.5% (GC)

ee: >99.5%

Species: hyalina ad Yellow Liquid vel solidum

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-1-Boc-3-Aminopiperidine (CAS: 188111-79-7) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	(R) -1-Boc-3-Aminopiperidine
Synonyma	(R)-(-)-3-Amino-1-Boc-Piperidine;(R) -1-Boc-3-Piperidinamine;tert-Butyl (R) -3-Amino-1-Piperidinecarboxylate
CAS Number	188111-79-7
CATTUS Number	RF-CC348
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C10H20N2O2
M. Pondus	200.28
Density	1.041±0.060 g/cm3
Index refractivus	1.473
Aqua Solubility	Cum aqua immiscibilis
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina ad Yellow Liquid vel solidum
Aqua Content (KF)	<0.50%
Puritas / Analysis Methodus	>99.5% (GC)
ee*	>99.5%
Imprimis rotationis [α]20/D	-30.5° ~ -26.5° (C=1 in DMF)
Infrared Imaginis	Conformat ut Structure
NMR	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Chiral Compositions;Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

(R) -1-Boc-3-Aminopiperidine (CAS: 188111-79-7) media in variis substantiis fabricandis sicut pharmaceutica.(R) -1-Boc-3-Aminopiperidine praecursor adhiberi potest ad praeparationem dipeptidyli peptidasi IV inhibitores sicut API (CAS: 36,1442-04-8), Linagliptin (CAS: 668270-12-0), Alogliptin (. CAS: 850649-61-5), aliorumque agentium antidiabeticorum.(CAS: 361442-04-8) medicamentum est 2 diabete genus, quod pancreas movet ad maiorem insulinum post prandium.Perventum est ab cooperatione AstraZeneca et Bristol-Myers Squibb Societatis et ad inhibitorem DPP-IV pertinet.Ludit in inhibitione GLP-l degradationis.GLP-I Est hormona quae naturaliter intestino cibo sumta nascitur.(CAS:361442-04-8) secretionem insulinae moderari et utendo glucosi in texturis periphericis roborare potest.Unius medicamen (CAS:361442-04-8) sanguinem glucosum emendare et medicamentum coniunctum (CAS:361442-04-8) cum metformino, sulfonylurea et thiazolidinediones augere potest effectum curativum.Perducit ad gravem periculum hypoglycemiae eiusque motus adversae similes placebo, tolerantiam meliorem ostendens.